This inventor holds 1 USPTO granted patent. Top assignee: University of California. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Ella Waters: Innovator in Cancer Research
Introduction
Ella Waters is a prominent inventor based in Berkeley, CA. She has made significant contributions to the field of cancer research, particularly in understanding the role of long intergenic non-coding RNAs (lincRNAs) in leukemia. Her innovative work has led to the development of methods and compositions that could potentially improve the diagnosis and treatment of certain cancers.
Latest Patents
Ella Waters holds a patent for her work titled "Methods and compositions involving lincRNA and leukemia." This patent highlights her discovery that lincRNA expression is associated with specific cytogenetic abnormalities and is related to the disease pathogenesis of certain cancers. The findings indicate that long intergenic non-coding RNAs play a crucial role in gene regulation, particularly in B acute lymphoblastic leukemia (B-ALL). The patent provides methods and compositions regarding B-ALL associated long intergenic RNAs (BALIRs), showcasing her innovative approach to cancer research. She has 1 patent to her name.
Career Highlights
Ella is affiliated with the University of California, where she continues her research and development in the field of cancer biology. Her work has garnered attention for its potential impact on understanding and treating leukemia, making her a valuable asset to the academic and scientific community.
Collaborations
Ella has collaborated with notable colleagues, including Dinesh S Rao and Norma I Rodriguez-Malave. These partnerships have further enriched her research and contributed to advancements in the understanding of cancer mechanisms.
Conclusion
Ella Waters is a dedicated inventor whose work in cancer research is paving the way for new diagnostic and therapeutic strategies. Her innovative contributions are essential in the ongoing fight against leukemia and other cancers.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
